These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37746066)

  • 21. Use of a mouse model to elucidate the phenotypic effects of the von Willebrand factor cleavage mutants, Y1605A/M1606A and R1597W.
    Pruss CM; Golder M; Bryant A; Hegadorn C; Haberichter S; Lillicrap D
    J Thromb Haemost; 2012 May; 10(5):940-50. PubMed ID: 22372972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [von Willebrand factor and von Willebrand disease].
    Matsui T; Hamako J
    Rinsho Ketsueki; 2016; 57(10):2113-2123. PubMed ID: 27795521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in von Willebrand factor and ADAMTS-13 in patients following arthroplasty.
    Liu L; Ling J; Ma Z; Yuan Q; Pan J; Yang H
    Mol Med Rep; 2015 Apr; 11(4):3015-20. PubMed ID: 25482054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: implications for hemostasis and clinical outcome.
    Hugenholtz GC; Adelmeijer J; Meijers JC; Porte RJ; Stravitz RT; Lisman T
    Hepatology; 2013 Aug; 58(2):752-61. PubMed ID: 23468040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased cleavage of von Willebrand factor by ADAMTS13 may contribute strongly to acquired von Willebrand syndrome development in patients with essential thrombocythemia.
    Kubo M; Sakai K; Hayakawa M; Kashiwagi H; Yagi H; Seki Y; Hasegawa A; Tanaka H; Amano I; Tomiyama Y; Matsumoto M
    J Thromb Haemost; 2022 Jul; 20(7):1589-1598. PubMed ID: 35352474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a Hyperactive Primary Hemostatic System During Off-Pump Lung Transplantation Resulting From an Unbalance Between von Willebrand Factor and Its Cleaving Protease ADAMTS13.
    Hugenholtz GC; Ruitenbeek K; Adelmeijer J; Pereboom IT; Meijers JC; van der Bij W; Porte RJ; Erasmus ME; Lisman T
    Am J Transplant; 2015 Jul; 15(7):1958-66. PubMed ID: 25846964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shear stress and von Willebrand factor in health and disease.
    Tsai HM
    Semin Thromb Hemost; 2003 Oct; 29(5):479-88. PubMed ID: 14631548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carboxyl terminus of ADAMTS13 directly inhibits platelet aggregation and ultra large von Willebrand factor string formation under flow in a free-thiol-dependent manner.
    Bao J; Xiao J; Mao Y; Zheng XL
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):397-407. PubMed ID: 24357063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting von Willebrand factor in liver diseases: A novel therapeutic strategy?
    Groeneveld DJ; Poole LG; Luyendyk JP
    J Thromb Haemost; 2021 Jun; 19(6):1390-1408. PubMed ID: 33774926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of von Willebrand factor and ADAMTS13 in patients with COVID-19: A systematic review and meta-analysis.
    Xu X; Feng Y; Jia Y; Zhang X; Li L; Bai X; Jiao L
    Thromb Res; 2022 Oct; 218():83-98. PubMed ID: 36027630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Ratio of von Willebrand Factor Antigen to ADAMTS13 Activity: Usefulness as a Prognostic Biomarker in Acute-on-Chronic Liver Failure.
    Takaya H; Namisaki T; Enomoto M; Kubo T; Tsuji Y; Fujinaga Y; Nishimura N; Kaji K; Kawaratani H; Moriya K; Akahane T; Matsumoto M; Yoshiji H
    Biology (Basel); 2023 Jan; 12(2):. PubMed ID: 36829443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombospondin-1 in von Willebrand factor function.
    Bonnefoy A; Hoylaerts MF
    Curr Drug Targets; 2008 Oct; 9(10):822-32. PubMed ID: 18855616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Intriguing Connections between von Willebrand Factor, ADAMTS13 and Cancer.
    Colonne CK; Favaloro EJ; Pasalic L
    Healthcare (Basel); 2022 Mar; 10(3):. PubMed ID: 35327035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Turbulent Flow Promotes Cleavage of VWF (von Willebrand Factor) by ADAMTS13 (A Disintegrin and Metalloproteinase With a Thrombospondin Type-1 Motif, Member 13).
    Bortot M; Ashworth K; Sharifi A; Walker F; Crawford NC; Neeves KB; Bark D; Di Paola J
    Arterioscler Thromb Vasc Biol; 2019 Sep; 39(9):1831-1842. PubMed ID: 31291760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. von Willebrand Factor, ADAMTS13 Activity, and Decline in Kidney Function: A Population-Based Cohort Study.
    Sedaghat S; de Vries PS; Boender J; Sonneveld MA; Hoorn EJ; Hofman A; de Maat MP; Franco OH; Ikram MA; Leebeek FW; Dehghan A
    Am J Kidney Dis; 2016 Nov; 68(5):726-732. PubMed ID: 27497525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alteration of plasma von Willebrand factor in the treatment of retinal vein occlusion with cystoid macular edema.
    Hirai H; Yamashita M; Matsumoto M; Nishiyama T; Wada D; Okabe N; Mizusawa Y; Jimura H; Ueda T; Ogata N
    PLoS One; 2022; 17(9):e0264809. PubMed ID: 36137144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered von Willebrand Factor and ADAMTS13 Levels in Children With Cirrhosis and Extrahepatic Portal Hypertension.
    Islek A; Ilhan D; Ozturk N; Guven B; Sag E
    J Pediatr Hematol Oncol; 2021 Oct; 43(7):e951-e956. PubMed ID: 33369998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ratio of von Willebrand factor antigen to ADAMTS13 activity is a useful biomarker for acute-on-chronic liver failure development and prognosis in patients with liver cirrhosis.
    Enomoto M; Takaya H; Namisaki T; Fujinaga Y; Nishimura N; Sawada Y; Kaji K; Kawaratani H; Moriya K; Akahane T; Inoue T; Matsumoto M; Yoshiji H
    Hepatol Res; 2022 Apr; 52(4):390-400. PubMed ID: 34964539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo imaging analysis of the interaction between unusually large von Willebrand factor multimers and platelets on the surface of vascular wall.
    Rybaltowski M; Suzuki Y; Mogami H; Chlebinska I; Brzoska T; Tanaka A; Banno F; Miyata T; Urano T
    Pflugers Arch; 2011 Jun; 461(6):623-33. PubMed ID: 21494805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical utility of far-infrared therapy for improvement of vascular access blood flow and pain control in hemodialysis patients.
    Choi SJ; Cho EH; Jo HM; Min C; Ji YS; Park MY; Kim JK; Hwang SD
    Kidney Res Clin Pract; 2016 Mar; 35(1):35-41. PubMed ID: 27069856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.